BioMarin Pharmaceutical(DE:BM8)
€50.92+0.28 (+2.50%)
DE:BM8
BioMarin Pharmaceutical Revenue
€50.92
At close:+0.28 (+2.50%)
BioMarin Pharmaceutical (BM8) Revenue
1 Followers
BioMarin Pharmaceutical Revenue
BioMarin Pharmaceutical had a revenue of 1.02B in the quarter ending Sep 30, 2026, with 3.53%. This bring the company's revenue in the last twelve months to 3.66B, Increased 7.30%. In the fiscal year ending Dec 31, 2025, BioMarin Pharmaceutical had annual revenue of 3.22B with 12.87% growth.
- Revenue (ttm)
- 3.66B
- Revenue Growth
- 13.99%
- P/S Ratio
- 3.08
- Revenue/Employee
- EUR 1,000,079
- Employees
- 3,221
- Market Cap
- EUR 9.91B
Revenue Chart
BioMarin Pharmaceutical Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.22B | 367.34M | 12.87% |
| Dec 31, 2024 | 2.85B | 434.69M | 17.97% |
| Dec 31, 2023 | 2.42B | 323.19M | 15.42% |
| Dec 31, 2022 | 2.10B | 249.76M | 13.53% |
| Dec 31, 2021 | 1.85B | -14.18M | -0.76% |
| Dec 31, 2020 | 1.86B | 156.41M | 9.18% |
| Dec 31, 2019 | 1.70B | 212.79M | 14.27% |
| Dec 31, 2018 | 1.49B | 177.61M | 13.52% |
| Dec 31, 2017 | 1.31B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.